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Abstract. We use a highly specific and sensitive anti-
body to further characterize the distribution of dystro-
phin in skeletal, cardiac, and smooth muscle. No evi-
dence for localization other than at the cell surface is
apparent in skeletal muscle and no 427-kD dystrophin
labeling was detected in sciatic nerve. An elevated con-
centration of dystrophin appears at the myotendinous
junction and the neuromuscular junction, labeling in
the latter being more intense specifically in the troughs
of the synaptic folds. In cardiac muscle the distribution
of dystrophin is limited to the surface plasma mem-
brane but is notably absent from the membrane that
overlays adherens junctions of the intercalated disks.
In smooth muscle, the plasma membrane labeling is
considerably less abundant than in cardiac or skeletal
D
STROPHIN is a large (427 kD) protein that is absent or
at very low levels in individuals suffering from Du-
chenne muscular dystrophy (Hoffman et al ., 1987a;
Hoffman et al., 1988a) . It is present in all types of muscle
(Hoffman et al., 1988b) and immunocytochemical studies
usinglight microscopy have localized the protein in skeletal
muscle to the sarcolemma (Arahata et al ., 1988; Bonilla et
al., 1988; Zubrzycka Gaarn et al., 1988). EM has shown
that dystrophin is closely apposed to the cytoplasmic surface
of the plasma membrane (Watkins et al., 1988; Carpenter et
al., 1990; Cullen et al ., 1990) and it has been shown bio-
chemically to associate tightly with a complex of membrane
glycoproteins (Campbell and Kahl, 1989). This localization,
the fact that membrane defects characterize Duchenne mus-
cular dystrophy (see Rowland, 1980 for review), and se-
quence similarities with other structural proteins such as
alpha-actinin and spectrin have led to speculation that
dystrophin is an important structural component of a mem-
brane skeleton that provides resilience to the plasma mem-
braneduring cycles ofcontraction and relaxation (Brown and
Hoffman, 1988 ; Koenig and Kunkel, 1990) .
In contrast with most immunocytochemical studies which
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muscle and is found in areas of membrane underlain
by membranous vesicles. As in cardiac muscle, smooth
muscle dystrophin seems to be excluded from mem-
brane above densities that mark adherens junctions.
Dystrophin appears as a doublet on Western blots of
skeletal and cardiac muscle, and as a single band of
lower abundance in smooth muscle that corresponds
most closely in molecular weight to the upper band of
the striated muscle doublet. The lower band of the
doublet in striated muscle appears to lack a portion of
the carboxyl terminus and may represent a dystrophin
isoform. Isoform differences and the presence of dystro-
phin on different specialized membrane surfaces imply
multiple functional roles for the dystrophin protein.
do not show labeling of structures internal to the surface
membrane, biochemical fractionation studies have indicated
that dystrophin cofractionates with transverse tubule mem-
branes (Hoffman et al., 1987b), and particularly with triads
(Knudson et al ., 1988; Salviati et al., 1989) . These findings
are important to confirm since the transverse tubules are not
subjected to the same deformations as the sarcolemma, and
the presence of dystrophin may suggest a different role for
the protein in this location as compared to the proposed
strengthening role at the plasma membrane. Such a conclu-
sion is also implied by the recent localization of dystrophin
to specific subsets of neuronal cells in the central nervous
system (Lidov et al., 1990), another tissue that does not un-
dergo dynamic changes in shape.
Additional evidence indicating a potentially more complex
functional role for dystrophin originates from studies of
skeletal muscle in which the neuromuscular junction and
myotendinousjunction have been reported to show increased
dystrophin labeling as compared to the rest of the sar-
colemma (Miike et al., 1989; Shimizu et al., 1989; Fardeau
et al., 1990; Samitt and Bonilla, 1990). However, in two
studies some labeling ofthe same structures was found in the
dystrophin-deficient mdx mouse (Fardeau et al., 1990;
Samitt and Bonilla, 1990), and dystrophin-deficient controls
were not utilized in a third (Shimizu et al., 1989) . In fact,
Fardeau et al. (1990) clearly establish the likely presence ofa protein that cross reacts with dystrophin antibodies, proba-
bly the dystrophin-related protein (Love et al., 1989;
Khurana et al., 1990) that has recently been shown to be
present at high concentrations in neuromuscularjunctions of
the rndx mouse (Khurana et al., 1991).
The dystrophin gene is transcribed into multiple RNA iso-
forms, some of which show a distinctive tissue specificity
(Chelly et al., 1988; Feener et al., 1989 ; Nudel et al., 1989) .
Corresponding isoforms at the protein level have not been
shown because of difficulties in resolving small changes in
the relative mobility of such a large protein with SDS-PAGE,
and because ofa lack of isoform-specific probes. Dystrophin
separates into two bands on western blots of mouse skeletal
and cardiac muscle under conditions of adequate resolution,
and a single band is seen in smooth muscle that was reported
to correspond to mobility to the lower skeletal muscle band
(Hoffman et al ., 19ß8b). On this basis it was proposed that
the lowerband in skeletal muscle might be a smooth muscle
isoform due to the presence of vascular tissue in the skeletal
muscle sample.
The object of this study was to use a new, highly specific
antibody to reevaluate the distribution ofdystrophin in skele-
tal muscle and to define its ultrastructural distribution in
other muscle types and peripheral nerve. This is important
in light of both cardiac and gastrointestinal involvement
in Duchenne muscular dystrophy (see Emery, 1988 for re-
view). In addition, we have optimized the resolution of dys-
trophin on SDS-PAGE/Western blots and examine it for iso-
form differences in the same tissues. We find that dystrophin
is differentially distributed with respect to membrane
specializations in all muscle tissues, and interpret this to im-
ply the likelihood of more than one functional role for the
protein.
Materials andMethods
SDS-PAGE, Antibodies, andImmunoblots
Tissues were frozen in liquid nitrogen, homogenized withoutprior thawing
in sample buffer (60 nilVí Tris-PO4, pH 6.8, 2.5 % [wt/voll SDS, 10 mM
EDTA, 50 mM DTT, 40ug/ml PMSF, 1 jig/mlpepstatin, 1 pg/ml leupeptin,
1.5 pg/ml aprotinin, and 10% glycerol), and were boiled for 4 min. Gel
samples were equalized according to total protein using a dotblot/amido
black staining procedure as described by Nakamura et al. (1985). Elec-
trophoresis was carried out using the Hoefer (San Francisco, CA) Mighty
Small slab gel apparatus and the buffersystem described by Laemmli (1971)
with the addition of 10 mM 2-mercaptoethanol to the running buffer. The
separating gel consisted of either 7% acrylamide, 0.08% N,M-methylene
bisacrylamide or a 3.5-12.5% acrylamide (0.1% bis in each) gradient; in
each case utilizing a 3% acrylamide, 0.08% bis stacking gel. Gels were
transferred to nitrocellulose as described by Burnette (1981).
The production and affinity purification ofantibody 6-10 was described
in Lidov et al. (1990). Briefly, the antibody was produced in a rabbit im-
munized with a dystrophin polypeptide expressed in bacteria from dystro-
phin cDNA residues 6,181-9,544. Antibody DI1 was described in Koenig
et al. (1990) and was purified by affinity to a polypeptide that was identical
inthe extent of its dystrophin sequences to the original immunogen (cDNA
residues 9,786-11,555). The polypeptide was produced in thepGEX vector
as described for the antibody 6-10 immunogen, and as in that preparation,
nondystrophin fusion sequences were removed before the coupling of the
dystrophinpolypeptideto Affi-Gel 10/15 affinity gel (Bio-Rad Laboratories,
Richmond, CA).
Western blots were stained with Ponceau red S (Sigma Chemical Co.,
St. Louis, MO) to check protein loading, rinsed with distilled water, TBS
plus 0.1% Tween-20, andthen blocked in TBS plus 0.1% Tween-20 and 5%
FCS. Blots were incubated with antibodies in TBS plus 0.1% Tween-20 and
5 % FCS overnightat4°C forthe primary and 1 h for the secondary antibody
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(1:1,000 dilution of alkaline phosphatase-conjugated goat anti-rabbit IgG
or donkey anti-sheep IgG; Sigma Chemical Co., St. Louis, MO), rinsing
between steps in the same buffer without FCS. Blots were developed by in-
cubation with 60 pg/ml nitro blue tetrazolium and 60 ug/n l 5 bromo-4-
chloro-3-indolyl phosphate in 0.15 M Tris-HCI, pH 8.8.
Sample PreparationforImmunocytochemistry
Mice were killed by chloroform inhalation and dissected along theirventral
midline, and fixed with2% formaldehydein 0.1 M PBS (pH 7.4) by ventric-
ular perfusion. After perfusion, the heart, regions of duodenum, and the
gastrocnemius, soleus, extensordigitorum longus, and superior rectusmus-
cles were removed. The samples were fixed in 2% formaldehyde, 0.01%
glutaraldehyde for an additional hour. Samples for EM were cut into 1-mm
cubes and immersed in 2.3 M sucrose overnight. Samples for thick (5 ,um)
frozen sections were immersed in 30% sucrose overnight.
After overnight infiltration with 30% sucrose, tissue samples were
mounted on filter paper and shock-frozen with CryoKwik (Damon) and
stored at -80°C for sectioning. Samples for EM were oriented on cutting
stubs and shock frozen in liquid nitrogen .
Immunocytochemistry
Frozen sections 5 pm thick were cut for light microscopy using an Ames
Cryostat II. Sections were lifted onto poly-L-lysine-coated glass slides and
maintained at -30°C until sectioning was complete. Sections were thawed
and rehydrated with 0.1 M PBS, blocked using 5% normal goat serum in
PBS, andlabeled with antibody 6-10at a dilution of0.2 pg/ml in PBS. After
three washes in PBS, the primary antibody was revealed using a 1:100 dilu-
tion of goat antirabbit rhodamine conjugate (Organon Teknika-Cappel,
Malvern, PA) in PBS. After a 1-h incubation with the second antibody, the
sections were washed three times in PBS, mounted in Gelvatol (Monsanto,
St. Louis, MO) and coverslipped. All observations were with a Zeiss Pho-
tomicroscope III.
Thin sections (70-100 nm) were cut using a Reichert Ultracut E micro-
tome (Reichert Scientific Instruments, Buffalo, NY) with an FC4D cryo-
attachment. Sections were lifted onto formvar-coated carbon grids and
washed three times in 0.1 M PBS. Nonspecific antibody binding was
blocked by subsequent washes in 0.1 M PBS containing 0.5% BSA and
0.15% glycine (buffer 1) followed by a 30 min incubation with 5 % normal
goat serum in buffer 1. After three further washes in buffer 1, sections were
incubated in 1 pg/ml antibody 6-10 in buffer 1 for 30 min, washed three
times in buffer 1, then incubated in 5-nm goat antirabbit gold conjugate
(Amersham Corp., Arlington Heights, IL) in buffer 1. They were then
washed three times in buffer 1, three times in PBS, three times in H2O and
counterstained with neutral 2 % uranyl acetate, followed by three washes in
H2O and stained for a further2 min in acidic 2% uranyl acetate. The grids
were mounted in 1.15% methyl cellulose in distilled H2O and dried. All
electronmicroscopic observations were withaJeol 100-CX II. Micrographs
were taken at a magnification of 29,000x .
Results
Western BlotAnalysis
The high specificity of antibody 6-10 for dystrophin in
mouse skeletal, cardiac, and smooth muscle is demonstrated
in Fig. 1 a. No labeling was observed in muscle tissues of
the dystrophin-deficient rndx mouse. Antibody 6-10 is
directed against a portion of dystrophin that is downstream
from the stop codon in the mdx mutation (Sicinski et al.,
1989), and consequently should not recognize even partial
products of dystrophin in this mutant. We did not observe
a band of similar mobility to dystrophin in sciatic nerve, but
a band is seen at -105 kD in this tissue from both normal
and mdx mice.
Dystrophin characteristically appears as a doublet in
skeletal and cardiac tissue under conditions that are adequate
to resolve the two bands (Hoffman et al., 198ßb and Fig. 1,
a, b, and d). The stoichiometry of the two bands is similar
from muscle prepared in different ways, using fresh or frozen
412Figure 1. Western blot analysis of dystrophin in mouse tissues. To
demonstrate the specificity of antibody 6-10, (a) gel samples of
muscle and nerve tissue as indicated (norm, normal mice ; mdx,
dystrophin deficient mice ; EDL, extensor digitorum longus) were
equalized according to total protein content, electrophoresed on
3.5-12.5% acrylamide gradient gels, and then transferred to
nitrocellulose. The blot was probed with 0.3 ag/ml antibody 6-10.
b-dcompare the reactivity of antibody 6-10 and carboxyl-terminal
antibody Dll with mouse muscle dystrophin . Gel samples were ad-
justed for comparable dystrophin staining and run on a7% acryl-
amide/0.08% his gel before transfer to nitrocellulose. b and c are
identical blots of the indicated tissues (Sol, soleus ; Car, cardiac)
probed with (b) 0.3 pg/ml antibody 6-10 and (c) 0.6 pg/ml antibody
Dll . To show that the upper antibody 6-10 reactive band corre-
sponds to the single D11 reactive band, in dadjacent strips from
a curtain gel of mouse heart tissue are stained as in b and c with
(lane 1) antibody 6-10 and (lane 2) antibody Dll .
tissue, with or without denaturing conditions in the initial
homogenization, and with different mixes ofprotease inhibi-
tors (not shown) . Thus, we believe that the lower band is
probably an isoform of dystrophin . Messenger RNA iso-
forms that could explain such differences in molecular mass
have been described (Feener et al., 1989) . Alternatively, if
the lower band is a degradation product, the proteolytic
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cleavage must be very rapid, specific, and must occur in a
characteristic subset of molecules (otherwise the stoichiom-
etry might be expected to vary with the preparation) . In any
case, such a cleavage would probably have physiological
significance, as with the limited cleavage of spectrin (fodrin)
by calpain (Harris and Morrow, 1990) .
We have used region-specific antibodies to determine
which region ofdystrophin might be missing from the lower
polypeptide band of the dystrophin doublet . The lower band
is not recognized by antibody D11 (Koenig and Kunkel,
1990) that was made against the carboxyl-terminal 486
amino acid residues of dystrophin (Fig . 1, cand d, lane 2),
but is recognized by antibody 6-10 which is directed against
the distal portion of the dystrophin repeat domain (Koenig
et al ., 1988) . The anti-3041) and anti-60-kD antibodies
against the middle andproximal regions ofthe repeatdomain
also recognize the lower band ofthe doublet (Hoffman et al .,
1987a and data not shown) . Therefore, based onour inability
to detect the lower band with antibody Dll, we presume that
the difference in mobility between the two bands is ac-
counted for by the absence of carboxyl-terminal sequences
in the lower form .
Intestinal smooth muscle displays a single dystrophin band
of lower intensity than that of skeletal and cardiac muscle
(Fig . 1 a) when equalized for total protein . This band runs
with a slightly lowerapparent molecular mass than the upper
band of the skeletal muscle doublet (Fig. 1, b and c), but the
two bands cannot be resolved in mixtures ofthe two samples
(data not shown) . One possible explanation for the apparent
difference in mobility could be differences in the composi-
tion of the two samples . In contrast to the conclusions of
Hoffman et al . (1988b), it is clear that smooth muscle dystro-
phin is more similar in molecular mass to the upper rather
than the lower band of the striated muscle doublet .
Immunocytochemical Analysis
Skeletal Muscle. Immunofluorescence microscopy of nor-
mal skeletal muscle with antibody 6-10 shows a typical
membrane localization for dystrophin with no labeling ap-
parent on internal structures of the muscle fibers. Also, no
labeling is seen in mdx mouse muscle (data not shown) . At
the electron microscope level (Fig . 2 a), labeling is also con-
centrated at the plasmamembrane and does not appear to be
associated with other membranous structures near the sur-
face or to extend within the muscle fiber. No labeling is seen
in the equivalent mdx tissue (Fig . 2 b) . When muscle is cut
at a slightly oblique angle, it is possible to visualize multiple
triadic structures between myofibrils (Fig. 2 c) . In such sec-
tions no labeling is seen with antidystrophin at transverse tu-
bule membranes within the muscle (Fig . 2c, open arrows),
though labeling associated with the surface membrane of the
same fiber in the same section is strong (Fig. 2 c, inset) .
When subcellular specializations of skeletal muscle are
examined, a considerable increase in the concentration of
antidystrophin labeling is seen at the myotendinous junction
of normal muscle (Fig . 3 a) . This label appears to extend fur-
ther into the muscle, away from the plasma membrane, con-
sistent with the increased subplasmalemmal density of the
myotendinous junction . When the myotendinous junction in
themdxmouse is examined using the same concentration of
antibody, no labeling is apparent (Fig . 3 b) .
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414The neuromuscular junction in the normal mouse also
reacts with antibody 6-10 (Fig. 3 c). We used one of the
small muscles of the eye, the superior rectus, to maximize
the number of end plates examined. We find that the crests
of the extensively folded neuromuscular junction membrane
reproducibly lack antidystrophin labeling. Labeling is con-
sistently found in the troughs and appears more intense than
that ofthe general plasma membrane. The same results were
observed in occasional endplates found in extensor digito-
rum longus muscle tissue. In the neuromuscular junction of
the mdx mouse, no labeling is apparent under the same con-
ditions (Fig. 3 d) .
Peripheral Nerve. No reactivity with antibody 6-10 was
found in immunocytochemistry of normal or mdx mouse
sciatic nerve (Fig. 3 e). Western blots also showed an ab-
sence of immunoreactivity in the expected region for full-
length dystrophin. A faintband was seen, however, at -105
kD in both normal and mdx mouse (Fig. 1 a) . This band
could be a cross-reactive protein, or it couldbe an alternate
product of the dystrophingene such as that described by Bar
et al., (1990). It is possible that this polypeptide is dis-
tributed diffusely in the cytoplasm, explaining the lack of
labeling in tissue sections.
Cardiac Muscle. Fluorescence microscopy shows that
dystrophin labeling clearly extends about the periphery (Fig.
4 a) and along the length of the cardiac myocyte (Fig. 4 c) .
No labeling is seen in cardiac tissue of the mdx mouse (Fig.
4 b), except for occasional positive fibers that are thought to
be reversions of the mdx mutation (data not shown, see
Hoffman et al., 1990). Occasional unlabeled myocytes may
be seen within the muscle of normal mice (one or two per
section of whole mouse ventricle; Fig. 4, c and d).
At the electron microscope level, dystrophin is limited to
the plasma membrane of the cardiocyte (Fig. 4 e) . The
plasma membrane in the region of the intercalated disk is not
labeled, however, and no labeling is seen on any ofthe mem-
brane systems within heart muscle such as transverse tubules
or triads (Fig. 4f). In the mdx mouse, no labeling ofany kind
is apparent within cardiac muscle at the EM level (data not
shown) .
Smooth Muscle. Light microscopy shows discontinuous
labeling of the surface membrane of smooth muscle cells. In
transverse section (Fig. 5 a, open arrows), the labeling ap-
pears punctate, and in longitudinal section (Fig. 5 a, closed
arrows), bars are seen that appear to run the length of the
cells. No labeling is present in the mdx mouse (Fig. 5 b).
At the electron microscope level, the labeling for dystro-
phin in smooth muscle is significantly less than that found
for skeletal or cardiac muscle and only occurs near the
plasma membrane, but is frequently found at a somewhat
greater distance from the membrane than in skeletal or
cardiac muscle. An example of what is considered strong
labeling of smooth muscle is shown in Fig. 5 c. A patchy dis-
tribution is seen that is consistent with the immunofiuores-
cence labeling. Labeling seems to be excluded from regions
ofmembrane underlain by denseplaques, and present below
themembrane ofintervening regions. It also occurs reprodu-
cibly on membranous structures below the plasma mem-
brane (Fig. 5 c, inset). No labeling is apparent in mdx mouse
smooth muscle under the same conditions (not shown).
Discussion
We have used a highly specific and sensitive antibody to
reevaluate the subcellular distribution of dystrophin in skele-
tal muscle and to examine its distribution in other muscle tis-
sues and in peripheral nerve. The presence of dystrophin in
regions of muscle and nerve cells that are specialized for
very different functions, and probable isoform diversity in
the dystrophin protein, argue that dystrophin may fulfill dis-
tinct functional roles in different locations.
Skeletal Muscle
Previous immunocytochemical work has shown the bulk of
dystrophin to be associated with the sarcolemma of skeletal
muscle (Arahata et al., 1988; Bonilla et al., 1988; Zubr-
zycka Gaarn et al., 1988) . Biochemical studies of skeletal
muscle membranes have suggested that dystrophin also
cofractionates with junctional transverse tubule membranes
(Hoffman et al., 1987b; Knudson et al., 1988; Salviati et al.,
1989), but this observation is not supported by immunocyto-
chemistry. The presence ofa membrane cytoskeletal protein
such as dystrophin at the triadic membranes could indicate
a role in the maintenance of either channel distribution
within the triad or the position of the triad structure itself
within the infrastructure of the sarcomere. Therefore, it is
important in a consideration ofthe possible functions ofdys-
trophin to confirm its subcellular distribution. In agreement
with other immunocytochemical studies (Bonilla et al.,
1988; Carpenter et al., 1990; Cullen et al., 1990), we find
a strong labeling at the plasma membrane, but no labeling
of internal structures or membranes. It is unlikely that dys-
trophin is being selectively extracted from internal mem-
branes with the techniques that we employ, therefore, we
suggest thatthere is little, ifany, dystrophinon internal mem-
branes relative to the plasma membrane. These conclusions
are also inagreement with arecentbiochemical fractionation
study that compared the dystrophin content of cleanly sepa-
rated sarcolemmal and transverse tubule fractions and
verified the content of the fractions using a number of well-
defined markers specific to skeletal muscle membrane frac-
tions (Ohlendieck et al., 1991).
At the myotendinous junction, thin filaments of the
myofibrils attach and transmit force via the membrane to ex-
tracellular structures. Antidystrophin labeling of this struc-
Figure 2. In skeletal muscle, labeling is found only at the plasma membrane. (a) This transverse ultrathin frozen section through normal
extensordigitorum longus muscle shows labeling under the plasmamembranebutnot associatedwith subplasmalemmal membranous struc-
tures when incubated with antibody 6-10. (b) In the mdx mouse, transverse sections of extensor digitorum longus muscle incubated with
the same antibody show no evidence oflabeling. (c) When muscle fibers are cut at a slightlyoblique angle, multiple triads may be visualized
in a single section. In this micrograph of normal muscle, no labeling of the triads (open arrows) is found. Representative labeling at the
surface of this fiber is shown in Fig. 2 c (inset) . Strong subplasmalemmal labeling for dystrophin is apparent. Bars, 0.2 /.m.
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416ture is more intense than that seen at the remainder of the
plasma membrane. This finding has been reported previ-
ously by Shimizu et al. (1989) and Samitt and Bonilla (1990),
but the former authors did not use a dystrophin-deficient con-
trol and the latter also reported some labeling in the same
location in muscle tissue of the mdx mouse. As it is known
that the mdx mouse lacks dystrophin, Samitt and Bonilla
(1990) suggested that they may be detecting another protein
besides dystrophin. The cross-reactive protein could possi-
bly be the recently described dystrophin-related protein
(Loveet al., 1989; Khurana et al., 1990) which shows strong
labeling at the mdx myotendinous junction by immunofluo-
rescence (Khurana et al., 1991). In this study we have been
able to titrate the concentration of antibody 6-10 to a level
that is completely negative for mdx muscle, but retains a
strong reaction in normal tissue and in the occasional rever-
tant fibers of mdx muscle (Hoffman et al., 1990). Thus, our
results confirm with a high degree of confidence that dystro-
phin is enriched at the myotendinous junction.
Tidball and Law (1991) have found a deficiency in the at-
tachment of actin filaments to myotendinousjunctions of the
mdx mouse. For this reason, and because of its elevated pres-
ence at myotendinousjunctions, dystrophin is proposed to be
an integral element in the transmission of tension from sar-
comeric actin filaments through the plasma membrane to the
tendon (Samitt and Bonilla, 1990; Tidball and Law, 1991).
As at the myotendinous junction, dystrophin seems to be
present in slightly higher abundance at neuromuscular junc-
tions, confirmingthe findings ofMiike et al. (1989), Shimizu
et al. (1989), and Fardeau et al. (1990) . Huard et al. (1991)
has suggested through inferential reasoning that dystrophin
might be present in presynaptic nerve terminals at the neu-
romuscular junction as well as at the muscle membrane. In
this high-resolution study, however, we do not find dystro-
phin on the neuronal side of the junction .
On thepostsynaptic membrane of the neuromuscularjunc-
tion,dystrophin shows a differential distribution with respect
to the junction folds. Other molecular components also seg-
regate into distinct domains in the extensively folded mem-
branes of the neuromuscular junctions. The acetylcholine
receptor and 43-kD protein are concentrated at the crests of
the junctional folds and Na+ channels and ankyrin are
found predominantly in the troughs (Flucher and Daniels,
1989) . Sodium channels are known to interact with ankyrin
(Srinivasan et al., 1988) and it is thought that ankyrin may
help to restrict the distribution of the channels by linkage to
the membrane cytoskeleton. Our localization of dystrophin
to the troughs ofthejunctional folds suggests the possible in-
volvement of dystrophin in such a membrane cytoskeletal
structure. The fact that these folds are less pronounced in
neuromuscularjunctions ofDMD patients (Jerusalemet al.,
1974) and mdx mice (Torres and Duchen, 1987) suggests a
structural role for dystrophin in maintaining the folded shape
of the membrane in this region. Also, in view of the central
importance of acetylcholine receptors to synaptic function,
an important corollary to this observation is their apparent
lack of co-localization with dystrophin. This finding cor-
roborates the lack of disruption of the distribution and quan-
tity of acetylcholine receptors in DMD patients, despite
changes in the folding of postsynaptic membranes (Sakaki-
bara et al., 1977) .
Cardiac Muscle
In quality and quantity, the general distribution ofdystrophin
on plasma membrane surfaces of cardiac muscle is almost
indistinguishable from skeletal muscle. This similarity is
also true of skeletal versus cardiac dystrophin on Western
blots. A major difference, however, is that a specialized por-
tion ofthe outer plasma membrane of cardiac muscle, the in-
tercalated disk, shows no labeling for this protein what-
soever. The intercalated disk contains adherens junctions
that anchor myofibrillar actin filaments and maintain inter-
cellular connections under tension. It has been suggested
(see above) that dystrophin plays a role in anchoring actin
filaments at the membrane ofthe myotendinous junctions of
skeletal muscle. Thus, it is surprising to find a complete ab-
sence of dystrophin at the membrane of the intercalated
disks.
We occasionally observed unlabeled cardiocytes in sec-
tions of heart tissue. We feel that this is likely to reflect so-
matic mutations in the dystrophin gene in the nucleus of
those particular cells. Such an event would not be as easily
observed in skeletal muscle fibers because of their syncytial
nature. A reciprocal phenomenon has been described in the
mdx mouse where occasional positive cardiac myocytes are
seen in a fieldof negatively staining cells. This has been at-
tributed to a somatic reversion of the mdx mutation in those
cells (Hoffman et al., 1990) .
Smooth Muscle
A significantly lower level of dystrophin is observed in
smooth muscle as compared with striated muscle, both by
Western blot analysis and immunocytochemistry. Also, the
distribution at the lightmicroscope level is discontinuous on
the surface of the smooth muscle cell, forming a pattern
that is stripe-like in longitudinal view and punctate in cross-
section. This distribution is very much like the pattern seen
Figure 3 Distribution of dystrophin at membrane specializations of skeletal muscle and in peripheral nerve. (a) Ultrathin longitudinal
section of normal skeletal muscle at the myotendinous junction shows strong labeling under the plasma membrane (solid arrows) with
antibody 6-10. The labeling here appears considerably more intense than that seen at the periphery of normal skeletal or cardiac muscle
(compare to Figs. 2 a and 4 e). Collagen fibrils can be seen in close association with the junction (open arrow). (b) Longitudinal section
through mdx skeletal muscle at the myotendinousjunction labeled under the same conditions as a. No labeling is seen under the membrane
(arrows) or in any other region. (c) Ultrathin frozen section through a neuromuscular junction in the superior rectus muscle of normal
mouse and labeled as ina. Within thefolded regionofthejunction the labelingis predominantly associatedwith thetroughs ofthepostsynap-
tic membrane and not with the crests (closed arrows). No labeling is seen at the neuronal endplate (EP). (d) Ultrathin frozen section
through a neuromuscularjunction in the superior rectus muscle ofmdx mouse and labeled as in 3 a. No labeling ofeither the crests (closed
arrows) or folds in this endplate is apparent. (e) No labeling is found within the peripheral nerve of normal mouse when labeled with
this antibody (open arrows delimit the axioplasm; M, mitochondrion). Bars, 0.2 Am.
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417Figure 4 . Dystrophin in cardiac muscle. (a) Transverse sectionthroughnormalperfusedcardiac ventricle showsuniform immunofluorescent
labeling about the periphery ofcardiocytes with antibody 6-10. (b) In themdx mouse, transverse sections of the cardiac ventricular tissue
show no label . (c) Longitudinal section throughnormal cardiac ventricle also showsuniformlabeling ofcardiocyte membranes . Onoccasion
in normal muscle, totally unlabeled cells are seen (arrows) . (d) Phase-contrast micrograph of c showing the cardiocyte that is negative
for dystrophin (arrows) . (e) Ultrathin frozen section of normal cardiac muscle labeled with antibody 6-10. Subplasmalemmal labeling is
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418Figure5 . Dystrophin distribution in smooth muscle . (a) Immunofluorescent labeling with antibody 6-10 in normal mouse smooth muscle
(duodenum) occurs in bars that appear to extend the length of cells cut in longitudinal section (outer layer of cells, solid arrows), and
in a punctate pattern about the periphery of cells cut in transverse section (inner layer of cells, open arrows). (b) In the nulx mouse no
labeling fordystrophin is seen in duodenum under similar conditions . (c) Ultrathin longitudinal sections ofnormal mouse gutsmooth muscle
labeled with antibody 6-10. The intensity oflabeling is less than that seen in skeletal or cardiac muscle. It is seen to be unevenly distributed
along the subplasmalemmal surface, being largely excluded from submembranous densities (closed arrows) and present in intervening
regions (open arrows) . The labeling does not appear as closely associated with the plasma membrane as in skeletal or cardiac muscle
and frequently appears on surface-associated caveolae (inset, open arrows). Bars : (a and b) 20 ttm; (c) 0.2 gym .
with antibodies to vinculin (Small, 1985), and talin(Drenck-
hahn et al ., 1988). In those studies, examination of isolated
cellsmade it clear that vinculin and talin arepresent in multi-
ple longitudinal ribs around the perimeter of each cell .
At theTEM level, the smooth muscle membrane displays
periodic zones that are underlain by vinculin and talin-
containing dense plaques (Geiger et al ., 1980 ; Drenckhahn
et al ., 1988) . In freeze etch EM, the smooth muscle mem-
brane is organizedin alternatingzonesofvesicle-rich surface
membrane and smooth membrane that correspond to the
denseplaque regions (Devine et al ., 1971) . We find that dys-
trophin is predominantly found in vesicle-rich areas, some-
clearly apparent (open arrows), though no labeling is seen at the membrane of intercalated disks (closed arrows) . (f) Ultrathin frozen
section of normal cardiac muscle labeled as in e. Atypical triadic structure ofcardiac muscle is seen (open arrow) . No label is associated
with the T-tubule or triads (M, mitochondrion) . Bars : (a-d) 20 14m, (e and f) 0.2 um .
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419timesassociated with vesicles and caveolae near the surface,
and not in areas containing dense plaques. These results sug-
gest that dystrophin and vinculin may occur in alternating
tracks.
FunctionalConsiderations
Dystrophin is probably capable of bifunctional binding to
both membrane elements (Campbell and Kahl, 1989; Ohlen-
dieck et al., 1991) and actin filaments of the cytoskeleton
(Hammonds, 1987; Byers et al ., 1989). Thus, dystrophin
may participate in a membrane skeletal structure that links
membrane elements such as channels and receptors to the
cytoskeleton, possibly playing a structural and/or regulatory
role with respect to these components. The primary func-
tional defect in Duchenne muscular dystrophy is thought to
be a destabilization of the muscle plasma membrane due to
defects in the dystrophin molecule. Our data, however, along
with the data of others, argues that the function ofdystrophin
is not simply limited to the stabilizationofthe muscle plasma
membrane.
Recently, dystrophin was shown to be present at synaptic
densities in neurons of the brain (Lidov et al., 1990). The
noncontractile nature of brain tissue implies a potentially
different role for dystrophin in this locale than at the muscle
plasma membrane, possibly serving to organize synaptic ele-
ments such as membrane receptors. It is possible that dystro-
phin is playing a similar role at the synapse ofthe neuromus-
cular junction, distinct from the functions it serves in the
nonjunctional plasma membrane of skeletal muscle. An-
other striking feature of the findings of Lidov et al. (1990)
was the apparent absence of detectable dystrophin in non-
synaptic regions of nervous tissue in the central nervous sys-
tem. We extend this finding to the peripheral nervous system
by our observation of a lack of detectable dystrophin in
sciatic nerve. Thus dystrophin does not fulfill a general
structural role for plasma membranes of the nervous system
as it is proposed to in muscle.
Isoform differences might be expected for dystrophin in
different specialized regions as has been observed for the
ankyrins and spectrins (see Bennett, 1990 for review), and
several isoforms have been described in the dystrophin tran-
script (Chelly et al., 1988; Feener et al., 1989; Nudel et al.,
1989). Although further resolution of small differences in
this high molecular weight protein will be difficult, we sug-
gest that the lowerband of the dystrophindoublet in striated
muscle is an isoform that lacks epitopes from the carboxyl
terminus. It does not appear to be a smooth muscle isoform
as proposed by Hoffman et al. (1988) from comparisons of
mouse skeletal muscle and uterus, though, because the sin-
gle dystrophinband in gut is more similar in mobility to the
upper band ofthe doublet. Instead, our data suggest that the
lowerband is an isoform that is specialized for a function that
is specific to striated muscle.
In smooth and cardiac muscle, adherens junctions
(marked by denseplaques under the membrane) anchor actin
microfilaments to the membrane and are responsible for
maintaining a transmembrane linkage to extracellular struc-
tures and adjacent cells under tension (see Geiger et al.,
1985 for review). We have found these structures to be the
only major regions of the surface membrane of muscle cells
that lack dystrophin. This contrasts with dystrophids pro-
posed role at the myotendinous junction, where it is enriched
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in submembrane densities and is thought to be involved in
the coupling of the myofibrillar apparatus to the membrane,
and beyond to the tendon (Samitt and Bonilla, 1990; Tidball
and Law, 1991) . Clearly this cannot be considereda general-
ized function of dystrophin in all muscle types.
The absence or very low level of dystrophin in peripheral
nerve and structures such as internal membranes of muscle
cells and adherens junctions of cardiac and smooth muscle
makes these locations unlikely sitesofaction for dystrophin .
On the other hand, probable isoform diversity and the pres-
ence of dystrophin in areas that are specialized for very
different functions, from membranes of contractile cells to
synaptic membranes, support the argument that dystrophin
is capable of multiple functional roles in different regions of
muscle and neuronal cells. Before the discovery of the dys-
trophin gene, the multisystemic involvement of muscle and
nerve hampered progress in determining the primary cause
of Duchenne muscular dystrophy. Further understanding of
the multifunctional nature of dystrophin will help to explain
the complexity of the Duchenne phenotype.
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Note Added in Proof. In a recent report that used different methods (Sea-
lock, R., M. H. Butler, N. R. Kramarcy, K.-X. Gao, A. A. Murnane,
K. Douville, and S. C. Froehner. 1990. J. Cell Biol. 113 :1133-1144), it
was also observed that dystrophin is present in deep regions of the folds
of neuromuscular junctions and absent from acetylcholine receptor-rich
domains.
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